WBA Jan 2026 12.500 put
| Previous close | 4.5000 |
| Open | 4.4500 |
| Bid | 4.3000 |
| Ask | 4.5000 |
| Strike | 12.50 |
| Expiry date | 2026-01-16 |
| Day's range | 4.3800 - 4.5000 |
| Contract range | N/A |
| Volume | |
| Open interest | 8.11k |
Insider MonkeyGoldman Thinks Walgreens Boots Alliance, Inc. (WBA) Is A Long-Term AI Stock Set To Rally Eventually
We recently published a list of Beyond the Tech Giants: 35 Non-Tech AI Opportunities. In this article, we are going to take a look at where Walgreens Boots Alliance, Inc. (NASDAQ:WBA) stands against the other not-tech AI stocks. Investors have been desperately searching for a safer way to play the AI boom that has swept the […]
Associated Press FinanceWalgreens to pay $106M to settle allegations it submitted false payment claims for prescriptions
Walgreens has agreed to pay $106 million to settle lawsuits that alleged the pharmacy chain submitted false payment claims with government health care programs for prescriptions that were never dispensed. The settlement announced on Friday resolves lawsuits filed in New Mexico, Texas and Florida on behalf of three people who had worked in Walgreens’ pharmacy operation. The lawsuits were filed under a whistleblower provision of the False Claims Act that lets private parties file case on behalf of the United States government and share in the recovery of money, the U.S. Justice Department said.
ReutersWalgreens paying $106.8 million to settle US prescription billing fraud charges
(Reuters) -Walgreens Boots Alliance agreed to pay $106.8 million to settle charges it fraudulently billed the U.S. government for prescriptions that were never dispensed, the Department of Justice said on Friday. The Justice Department said Walgreens violated the federal False Claims Act between 2009 and 2020 by submitting payment claims to Medicare, Medicaid and other healthcare programs for prescriptions it processed but which were never picked up. This caused the pharmacy chain to receive tens of millions of dollars for prescriptions it never provided to patients, the department said.
